Advanced Medical Solutions stock rises on strong H1 2025 outlook

Published 15/07/2025, 09:46
 Advanced Medical Solutions stock rises on strong H1 2025 outlook

Investing.com -- Advanced Medical (TASE:BLWV) Solutions Group plc (LON:AMS (VIE:AMS2)) stock rose 3% after the company announced expectations for solid first-half 2025 financial results, with revenue projected at approximately £110 million.

The medical technology firm said it anticipates adjusted EBITDA of £24.0-24.5 million for the period. While consensus estimates weren’t available for the first half specifically, the company stated that performance "remains in line with expectations" and expressed confidence in meeting full-year targets.

Advanced Medical Solutions highlighted "strong underlying momentum" in its core surgical product portfolio. The integration of recent acquisitions Peters Surgical and Syntacoll is progressing well, according to the company.

The firm also completed the restructuring of its Wound Care business by the end of March, which has already resulted in improved margins for that segment beginning in the second quarter.

The company noted that full-year expectations imply an H2 weighting to both revenues and EBITDA, suggesting stronger performance in the latter half of 2025.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.